Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

NCT04726371 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2020
Completion date
November 30, 2022
Enrollment
415 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axis i diagnosis, coronavirus, covid19, developmental disability, intellectual disability, mental illness